Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Cornerstone Therapeutics says FDA advisers recommend against approving its drug lixivaptan
Cornerstone Therapeutics says FDA advisers recommend against approving its drug lixivaptan
Cornerstone Therapeutics says FDA advisers recommend against approving its drug lixivaptan
Submitted by
admin
on September 13, 2012 - 4:10pm
Source:
Yahoo/AP
News Tags:
Cornerstone Therapeutics
FDA
advisory panel
hyponatremia
lixivaptan
Headline:
Cornerstone Therapeutics says FDA advisers recommend against approving its drug lixivaptan
Do Not Allow Advertisers to Use My Personal information
